Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

scientific article

Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials. is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P356DOI10.1016/S0140-6736(09)60552-3
P698PubMed publication ID19303634

P50authorPatrick W SerruysQ63253317
Christian W HammQ66829316
Didier CarrieQ68077344
Douglas K OwensQ98149051
Rodney StablesQ38590246
Maria M. BrooksQ41533938
Sheryl F. KelseyQ42124184
Mark A. HlatkyQ56166694
Kathryn M. McDonaldQ59748119
P2093author name stringAlfredo Rodriguez
Marcus Flather
Eric Boersma
Nicolas Danchin
Stuart J Pocock
Dena M Bravata
Neuza Lopes
Spencer B King
Tim C Clayton
Jean Booth
Derek B Boothroyd
Andrzej S Kosinski
Ulrich Sigwart
Whady A Hueb
Jan Kähler
P2860cites workThree-year follow-up of the Argentine Randomized Trial of Percutaneous Transluminal Coronary Angioplasty Versus Coronary Artery Bypass Surgery in Multivessel Disease (ERACI)Q71020149
A meta-analysis of randomized controlled trials comparing coronary artery bypass graft with percutaneous transluminal coronary angioplasty: one- to eight-year outcomesQ73298948
Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study GroupQ73661215
Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization modeQ73762947
Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplastyQ73841644
Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of AnginaQ77530104
The final 10-year follow-up results from the BARI randomized trialQ80157921
Selection of surgical or percutaneous coronary intervention provides differential longevity benefitQ80333603
13-year follow-up of the German angioplasty bypass surgery investigationQ81884927
Evidence for use of coronary stents. A hierarchical bayesian meta-analysisQ28205005
Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) InvestigatorsQ28281001
Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. ACE-Inhibitor Myocardial Infarction Collaborative GroupQ30596519
Meta-analysis of individual patient data from randomized trials: a review of methods used in practice.Q31016826
Meta-analysis of the literature or of individual patient data: is there a difference?Q34334544
Long-term outcomes of coronary-artery bypass grafting versus stent implantationQ34421559
Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) TrialQ34740055
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery diseaseQ34948400
Treating individuals 4: can meta-analysis help target interventions at individuals most likely to benefit?Q36017145
Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working GroupQ36790212
Systematic review: the comparative effectiveness of percutaneous coronary interventions and coronary artery bypass graft surgery.Q36972301
Meta-analysis of randomised trials comparing coronary angioplasty with bypass surgeryQ39361157
Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplastyQ39484680
Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the DepartQ43408475
A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stentsQ45019905
The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design.Q45230904
Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST)Q50658760
Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.Q51055015
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.Q51179164
Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II).Q51372326
Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial.Q51372330
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.Q51681449
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsQ54066813
Randomized, Controlled Trial of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery DiseaseQ57589046
P433issue9670
P407language of work or nameEnglishQ1860
P921main subjectpatientQ181600
coronary artery bypass surgeryQ186020
cardiac surgeryQ235007
collaborationQ1145523
data collaborationQ96060107
P304page(s)1190-1197
P577publication date2009-03-19
P1433published inThe LancetQ939416
P1476titleCoronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials
P478volume373

Reverse relations

cites work (P2860)
Q56770452Q56770452
Q379538852011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventi
Q446337822013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: established knowledge and evidence gaps
Q222419222014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Q30653434A systematic review of individual patient data meta-analyses on surgical interventions
Q37131837A two-stage Bayesian design with sample size reestimation and subgroup analysis for phase II binary response trials
Q33647497ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy
Q37626030Adoption and effectiveness of internal mammary artery grafting in coronary artery bypass surgery among Medicare beneficiaries.
Q46231868Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II.
Q38177869Angina pectoris: current therapy and future treatment options
Q37607416Assessment of a method to detect signals for updating systematic reviews
Q36402889Association of Angiotensin-Converting Enzyme Genotype, Insertion/Deletion Polymorphism and Saphenous Vein Graft Atherosclerosis in Iranian Patients
Q84544342Best way to revascularize patients with main stem and three vessel lesions: patients should undergo PCI!
Q49555606Bilateral Versus Single Internal Thoracic Artery Grafts.
Q46098036Biophysical Cueing and Vascular Endothelial Cell Behavior.
Q37659163CABG in 2012: Evidence, practice and the evolution of guidelines
Q45063559CABG or PCI for revascularisation in patients with diabetes?
Q84135615CABG versus PCI for multivessel coronary artery disease
Q35530702Cardiac rehabilitation versus standard care after aortic aneurysm repair (Aneurysm CaRe): study protocol for a randomised controlled trial
Q44939466Cardiovascular disease: Is CABG really better than PCI in dialysis patients?
Q36295813Case 5/2015 - 88-Year-Old Female with Chronic Coronary Artery Disease, Upper Limb Thrombosis, Atrial Fibrillation and Cardiac Arrest
Q35778266Changes in the Practice of Coronary Revascularization between 2006 and 2010 in the Republic of Korea
Q42322686Changes in the safety paradigm with percutaneous coronary interventions in the modern era: Lessons learned from the ASCERT registry
Q30492121Chronic coronary artery disease: diagnosis and management
Q37647406Clinical Outcomes in Diabetic Patients Who Underwent Percutaneous Coronary Intervention during the Plain Old Balloon Angioplasty (POBA)-, Bare Metal Stents (BMS)- and Drug-eluting Stents (DES)-eras from 1984 to 2010.
Q41112088Clinical Trials Versus Clinical Practice: When Evidence and Practice Diverge--Should Nondiabetic Patients With 3-Vessel Disease and Stable Ischemic Heart Disease Be Preferentially Treated With CABG?
Q38071219Clinical evidence versus patients' perception of coronary revascularization
Q38162889Comparative effectiveness of antiarrhythmic drugs on cardiovascular hospitalization and mortality in atrial fibrillation
Q34017377Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
Q33983793Comparative effectiveness of multivessel coronary bypass surgery and multivessel percutaneous coronary intervention: a cohort study
Q36351313Comparative effectiveness of revascularization strategies
Q38153783Comparative effectiveness of revascularization strategies in stable ischemic heart disease: current perspective and literature review
Q41414051Comparing hospital performance within and across countries: an illustrative study of coronary artery bypass graft surgery in England and Spain.
Q26766572Comparing the Clinical Outcomes Between Insulin-treated and Non-insulin-treated Patients With Type 2 Diabetes Mellitus After Coronary Artery Bypass Surgery: A Systematic Review and Meta-analysis
Q38195447Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials
Q35434402Comparison of percutaneous coronary intervention with drug eluting stents versus coronary artery bypass grafting in patients with multivessel coronary artery disease: Meta-analysis of six randomized controlled trials
Q33924170Composite outcomes in coronary bypass surgery versus percutaneous intervention
Q40202463Conditions for confounding of interactions
Q26864819Conduits for coronary bypass: strategies
Q92899254Coronary Artery Bypass Graft Surgery Improves Survival Without Increasing the Risk of Stroke in Patients with Ischemic Heart Failure in Comparison to Percutaneous Coronary Intervention: A Meta-Analysis With 54,173 Patients
Q33740804Coronary Artery Bypass Grafting vs. Drug-Eluting Stent Implantation for Multivessel Disease in Patients with Chronic Kidney Disease
Q38896783Coronary Stents in Diabetic Patients: State of the Knowledge
Q34052895Coronary artery bypass graft type and outcomes in maintenance dialysis
Q38217328Coronary artery bypass grafting versus drug-eluting stents in patients with severe coronary artery disease and diabetes mellitus: systematic review and meta-analysis
Q26830855Coronary artery bypass grafting: Part 1--the evolution over the first 50 years
Q36355228Coronary artery disease and diabetes mellitus
Q35193488Coronary artery disease in type 2 diabetes mellitus: Recent treatment strategies and future perspectives
Q83904156Coronary artery disease: Risk models for revascularization--the search continues
Q44063681Coronary artery disease: revascularization strategies for patients with CAD and diabetes
Q51034959Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease.
Q34312812Coronary collaterals and risk for restenosis after percutaneous coronary interventions: a meta-analysis
Q36801055Coronary intervention in diabetes: is it different
Q83694476Coronary revascularization in diabetic patients. A focus on the 3-year SYNTAX trial outcomes
Q34789840Coronary revascularization in diabetic patients: Current state of evidence.
Q26778104Coronary revascularization in the elderly with stable angina
Q89612564Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention
Q37926750Current concepts on coronary revascularization in diabetic patients
Q37663898Current options for treatment of chronic coronary artery disease
Q83694813Debate over patient-centered care: percutaneous coronary intervention or coronary artery bypass grafting?
Q35957953Demographic and Socioeconomic Factors of Patients With Coronary Artery Diseases Undertreatment of Coronary Artery Bypass Grafting, Percutaneous Coronary Intervention and Drug Therapy in Mashhad, Iran
Q35739868Determinants of variations in coronary revascularization practices
Q33647298Diabetes and cardiovascular disease: from evidence to clinical practice - position statement 2014 of Brazilian Diabetes Society.
Q42332217Diabetes mellitus and multivessel coronary artery disease: an ongoing battle for an ideal treatment strategy
Q38018724Diabetes mellitus and the heart
Q45781910Differences in baseline characteristics, practice patterns and clinical outcomes in contemporary coronary artery bypass grafting in the United States and Europe: insights from the SYNTAX randomized trial and registry
Q41889254Drug-eluting stents in multivessel coronary artery disease: cost effectiveness and clinical outcomes
Q22241786ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary
Q36913808Early risk of mortality after coronary artery revascularization in patients with left ventricular dysfunction and potential role of the wearable cardioverter defibrillator
Q89876090Economic Analysis of Surgical and Interventional Treatments for Patients with Complex Coronary Artery Disease: Insights from a One-Year Single-Center Study
Q45301806Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial
Q48002756Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions
Q30660247Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data
Q28548148Efficacy and Safety of Intracoronary versus Intravenous Administration of Tirofiban during Percutaneous Coronary Intervention for Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials
Q34999733Efficient gene transfer and durable transgene expression in grafted rabbit veins
Q37588002Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.
Q36248124Executive Summary of the Guidelines on Stable Coronary Disease
Q36746495Frequency and Predictors of Internal Mammary Artery Graft Failure and Subsequent Clinical Outcomes: Insights From the Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT) IV Trial
Q28079800Has the difference in mortality between percutaneous coronary intervention and coronary artery bypass grafting in people with heart disease and diabetes changed over the years? A systematic review and meta-regression
Q39752158Hospital Surgical Volumes and Mortality after Coronary Artery Bypass Grafting: Using International Comparisons to Determine a Safe Threshold.
Q38031999How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches
Q34925593Immediate Postoperative Complications in Patients Undergoing CABG; Investigating the Role of Prior Coronary Stenting
Q34719102Impact of drug-eluting stents on the comparative effectiveness of coronary artery bypass surgery and percutaneous coronary intervention.
Q36353650Impact of the SYNTAX scores I and II in patients with diabetes and multivessel coronary disease: a pooled analysis of patient level data from the SYNTAX, PRECOMBAT, and BEST trials
Q44337285In vivo study of a model tissue-engineered small-diameter vascular bypass graft
Q51157089In vivo study of alginate hydrogel conglutinating cells to polycaprolactone vascular scaffolds fabricated by electrospinning.
Q36533510Incomplete revascularization in the drug eluting stent era permits meaningful long-term (12-78 months) outcomes in patients ≥ 75 years with acute coronary syndrome
Q21559668Individual participant data meta-analysis for a binary outcome: one-stage or two-stage?
Q38777054Influence of practice patterns on outcome among countries enrolled in the SYNTAX trial: 5-year results between percutaneous coronary intervention and coronary artery bypass grafting†.
Q37633665Inhibition of vein graft stenosis with a c-jun targeting DNAzyme in a cationic liposomal formulation containing 1,2-dioleoyl-3-trimethylammonium propane (DOTAP)/1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE).
Q27013126Is the advantage of coronary bypass graft surgery over percutaneous coronary intervention in diabetic patients with severe multivessel disease influenced by the status of insulin requirement?
Q38689158Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation
Q36836240Long-Term Risk of Stroke in Patients With Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting
Q36658583Long-term Outcome after Percutaneous Coronary Intervention Compared with Minimally Invasive Coronary Artery Bypass Surgery in the Elderly
Q47687627Long-term clinical outcomes, health-related quality of life, and costs in different treatment modalities of stable coronary artery disease
Q34427865Long-term mortality in minimally invasive compared with sternotomy coronary artery bypass surgery in the geriatric population (75 years and older patients).
Q35734651Long-term mortality of coronary artery bypass grafting and bare-metal stenting
Q37390057Long-term survival after coronary bypass surgery and percutaneous coronary intervention
Q30248679Long-term use of dual antiplatelet therapy for the secondary prevention of atherothrombotic events: Meta-analysis of randomized controlled trials
Q39913995Major themes for 2009 in cardiothoracic and vascular anesthesia
Q38106502Management of the patient with diabetes and coronary artery disease: a contemporary review
Q30239853Management standards for stable coronary artery disease in India
Q43705921Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis
Q26829693Meta-analysis of three randomized controlled trials comparing coronary artery bypass grafting with percutaneous coronary intervention using drug-eluting stenting in patients with diabetes
Q41500175Morphology of Coronary Ostia in Domestic Shorthair Cat.
Q52373206Mortality after coronary artery bypass grafting versus percutaneous coronary intervention with stenting for coronary artery disease: a pooled analysis of individual patient data.
Q36426128Multivessel coronary artery bypass grafting versus percutaneous coronary intervention in ESRD.
Q46167057Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus
Q38124877Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice
Q37277273Multivessel coronary revascularization and outcomes in kidney transplant recipients
Q82433396Multivessel percutaneous coronary intervention in patients with stable angina: a common approach? Lessons learned from the EHS PCI registry
Q36087918Myocardial revascularization for the elderly: current options, role of off-pump coronary artery bypass grafting and outcomes
Q87615885Neurological complications of cardiac surgery
Q37111596New frontiers in cardiovascular behavioral medicine: comparative effectiveness of exercise and medication in treating depression
Q48194887Nine-month clinical outcomes in patients with diabetes treated with polymer-free sirolimus-eluting stents and 6‑month vs. 12‑month dual-antiplatelet therapy (DAPT).
Q37887771Nitric oxide: a guardian for vascular grafts?
Q34281305Off-pump coronary artery bypass surgery and acute kidney injury: a meta-analysis of randomized controlled trials.
Q39410697Optimal choice of coronary revascularization and stent type in diabetic patients with coronary artery disease
Q38138348Optimal revascularization for complex coronary artery disease
Q38679722Optimal use of arterial grafts during current coronary artery bypass surgery
Q47134510Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus
Q37066652Outcomes of DES in Diabetic and Nondiabetic Patients with Complex Coronary Artery Disease after Risk Stratification by the SYNTAX Score
Q85646078Overview: Japanese guidelines for myocardial revascularization to treat stable ischemic heart disease 2012
Q83514069PCI or CABG in coronary artery disease?
Q38225459Percutaneous coronary intervention compared with coronary artery bypass graft in coronary artery disease patients with chronic kidney disease: a systematic review and meta-analysis
Q91605679Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study
Q82791112Percutaneous coronary intervention in the elderly
Q37561885Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndrome
Q26471346Percutaneous coronary intervention versus coronary artery bypass grafting for adults with diabetes and multivessel coronary disease
Q84471489Percutaneous coronary interventions for all patients with complex coronary artery disease: triple vessel disease or left main coronary artery disease. Yes? No? Don't know?
Q38071968Perioperative control of blood glucose level in cardiac surgery
Q34497302Postoperative Staphylococcus aureus infections in Medicare beneficiaries
Q36896610Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality
Q44005280Prevalence and procedural outcomes of percutaneous coronary intervention and coronary artery bypass grafting in patients with diabetes and multivessel coronary artery disease
Q28070388Psychosocial Factors in Diabetes and Cardiovascular Risk
Q46456558Randomized trials of PCIs versus CABG surgery: why coronary stenting should remain the first choice of revascularization in non-diabetic patients and why the controversy is still present in diabetics
Q45954313Rationality and the generalization of randomized controlled trial evidence.
Q38875527Revascularization Strategies in Patients with Diabetes Mellitus and Acute Coronary Syndrome.
Q38735428Revascularization for Advanced Coronary Artery Disease in Type 2 Diabetic Patients: Choosing Wisely Between PCI and Surgery
Q34793647Revascularization for coronary artery disease in diabetes mellitus: angioplasty, stents and coronary artery bypass grafting
Q38013670Revascularization for left main and multivessel coronary artery disease in the drug-eluting stent era: integration of recent drug-eluting stent trials
Q38779868Revascularization in ischemic heart failure with reduced left ventricular ejection fraction. The impact of complete revascularization
Q38353639Revascularization in patients with diabetes: PCI or CABG or none at all.
Q35739893Revascularization options: one size does not fit all.
Q37827869Revascularization treatment of stable coronary artery disease
Q30815345Reviews of individual patient data (IPD) are useful for geriatrics: an overview of available IPD reviews
Q36092782Role of CABG in the management of obstructive coronary arterial disease in patients with diabetes mellitus
Q53655124SYNTAX-justified trend toward restricting coronary artery bypass grafting to more serious cases.
Q34224601Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association
Q84850268Secondary prevention of ischaemic cardiac events
Q37407828Severe ischemic cardiomyopathy-a new answer in management?
Q42126164Short, Intermediate and long term outcomes of CABG vs. PCI with DES in Patients With Multivessel Coronary Artery Disease. Meta-Analysis of Six Randomized Controlled Trials
Q35619894Significance of off-pump coronary artery bypass grafting compared with percutaneous coronary intervention: a propensity score analysis
Q38579536Stable coronary artery disease: revascularisation and invasive strategies
Q64970571Stent versus Coronary Artery Bypass Surgery in Multi-Vessel and Left Main Coronary Artery Disease: A Meta-Analysis of Randomized Trials with Subgroups Evaluation.
Q42552195Stents or surgery in coronary artery disease in 2013.
Q87976847Strategies for multivessel revascularization in patients with diabetes: the FREEDOM trial
Q34771915Surgical ineligibility and mortality among patients with unprotected left main or multivessel coronary artery disease undergoing percutaneous coronary intervention
Q38262668Surgical versus percutaneous revascularization in patients with multivessel coronary artery disease
Q40849348The SYNTAX score is correlated with long-term outcomes of coronary artery bypass grafting for complex coronary artery lesions
Q35190270The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes).
Q37725477The evolution of cardiovascular surgery in elderly patient: a review of current options and outcomes
Q41076426The impact of type 2 diabetes mellitus on prognosis in patients with non-ST elevation myocardial infarction.
Q42613034The potential of cellular technology to mediate social networks for support of chronic disease self-management
Q36982530The role of CABG in the era of drug-eluting stents: a surgeon's viewpoint
Q37306857The role of glucose lowering agents on restenosis after percutaneous coronary intervention in patients with diabetes mellitus
Q84121722The role of revascularization versus medical therapy in patients with type 2 diabetes mellitus and coronary artery disease
Q41870519The use of modern interventional cardiology tools to verify lesion significance and optimize procedural outcome in a diabetic patient with multivessel disease
Q24289039Three simple rules to ensure reasonably credible subgroup analyses
Q38049323Total arterial coronary artery bypass grafting in patients with diabetes: an 8-year experience
Q28539350Treatment for stable coronary artery disease: a network meta-analysis of cost-effectiveness studies
Q58009187Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial†
Q33971106Trends in acute kidney injury, associated use of dialysis, and mortality after cardiac surgery, 1999 to 2008.
Q38152246Trialogue Plus: Management of cardiovascular risk in hyperglycaemic/diabetic patients at hospital discharge
Q38558645Understanding the Outcome of Randomized Trials with Drug-Eluting Stents and Coronary Artery Bypass Graft in Patients with Multivessel Disease: A Review of a 25-Year Journey
Q37644740Unprotected left main percutaneous coronary intervention in a 108-year-old patient
Q58592681Up to 15-Year Survival of Men and Women after Percutaneous Coronary Intervention Paid by the Brazilian Public Healthcare System in the State of Rio de Janeiro, 1999-2010
Q36327454Will comparative effectiveness research finally succeed?
Q89447942[Cardiac surgery in the elderly]
Q53737554[Comments on the 2013 ESC/EASD guidelines on diabetes, prediabetes and cardiovascular diseases].
Q82239222[Modern coronary surgery, the SYNTAX trial and updated guidelines]
Q51359252[Prevalence of undetected diabetes mellitus in invasive and interventional cardiology. Silent diabetes in the catheterization laboratory].
Q22242895ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment el

Search more.